Cargando…
Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia/reperfusion model
Bilirubin was previously considered a toxin byproduct of heme catabolism. However, a mounting body of evidence suggests that at physiological doses, bilirubin is a powerful antioxidant and anti-atherosclerotic agent. Recent clinical studies have shown that human beings with genetically-induced hyper...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927123/ https://www.ncbi.nlm.nih.gov/pubmed/24600401 http://dx.doi.org/10.3389/fphys.2014.00053 |